Efficiency of Acute Stroke Fast Track Network with an Integrated Intravenous Thrombolytic Therapy: Buriram Hospital in Rural of Thailand

Main Article Content

Suppachok Wetchaphanphesat

Abstract

Background: Although intravenous (IV) recombinant tissue plasminogen activator (rt-PA) given within ischemic stroke patient is most important treatment. The benefits of an acute stroke referral network for IV thrombolytic therapy in rural area of developing country remain controversial.
Objective: We present efficiency of Acute stroke Fast Track Network with an integrated intravenous thrombolytic therapy: Buriram hospital in rural of Thailand, and compare the results with previously published data.
Setting: Buriram hospital and hospital in Buriram Acute stroke Fast Track Network.
Method: A prospective descriptive study was done in 1280 patients with acute onset symptoms of stroke referred from hospitals in the Buriram Acute stroke Fast Track Network, other hospital in Buriram province or walk-ins. admitted to the medicine division of Buriram hospital between November 2010 and July 2011. The main outcome measure were IV thrombolytic treatment rate, initial National Institutes of Health stroke Scale (NIHSS) score, door to needle time, onset to treatment time, mean door to CT time, mean door to LAB time, intracerebral hemorrhage and morbidity and mortality at 3 months after onset (เทRร).
Result: A 939 patients of 1280 were ischemic stroke (73%). A total of 37 patients recruited to Buriram hospital Acute stroke Fast Track Protocol and 20 patient (54%) of those referred from Buriram Acute Stroke Fast Track Network. Six patients (16%) among 37 patients from Buriram hospital Acute stroke Fast Track Protocol were received IV thrombolytic therapy. The mean of initial National Institutes of Health Stroke Scale (NIHSS) score before thrombolytic therapy was 14 (range 8-19), mean door to needle time was 73 minutes (range 64-88), mean onset to treatment time was 154 minutes (range 23-225), mean door to CT time was 27 minutes (range 20-34), mean door to LAB time was 28.75 minutes (range 21-45), intracerebral hemorrhage was 1 patient (16%) and morbidity and mortality at 3 months after onset which modified Rankin Scale score [เทRร] of 0-6), fmRS 0-1] was 2 patients (33%) , [mRS 2-3] was 2 patients (33%) , [เทRร 4-5] was 1 patient (17%), [เทRร=6] was 1 patient (17%). These outcomes are less efficiency than in the National institute of Neurological Disorder and stroke and in Thailand studies.
Conclusion: Our finding indicated that proper Acute Stroke Fast Track Network with an integrated intravenous thrombolytic therapy: Buriram hospital in rural of Thailand where inexperienced center with this therapy is safe and feasible although less efficiency. Empowerment of network and stroke alert promotion in community can reproduce the experience and outcome that should improve the rate of thrombolytic therapy in rural of Thailand.

Article Details

How to Cite
Wetchaphanphesat, S. (2018). Efficiency of Acute Stroke Fast Track Network with an Integrated Intravenous Thrombolytic Therapy: Buriram Hospital in Rural of Thailand. MEDICAL JOURNAL OF SISAKET SURIN BURIRAM HOSPITALS, 26(3), 353–404. retrieved from https://he02.tci-thaijo.org/index.php/MJSSBH/article/view/133641
Section
Original Articles

References

Matsuda Y, Kurita T, Ueda Y, Ito ร, Nakashima T. Effect of tympanic membrane perforation on middle-ear sound transmission. J Laryngol Otol May 2009; 123 Suppl 31:81-9. [Medline].

Wright D, Safranek S. Treatment of otitis media with perforated tympanic membrane. Am Fam Physician. Apr 15 2009;79(8):650, 654. [Medline].

Vikram BK, Khaja N, udayashankar SG, Venkatesha BK, Manjunath D. Clinico- epidemiological study of Complicated and uncomplicated chronic suppurative otitis media. J laryngol Otol. May 2008; 122(5):442-6. [Medline].

Smith JA, Danner CJ. Complications of chronic otitis media and cholesteatoma. Otolaryngol Clin North Am. Dec 2006; 39(6): 1237-55. [Medline].

Brown OE, Meyerhoff WL. Complications and Sequelae of Chronic Suppurative Otitis Media. Ann Otol Rhinol Laryngol. 1988;97(suppl 131):38-40.

Shenoi PM. Management of Chronic supperative otitis media. In: Scott-Brown’s Otolaryngology :Otology,Booth JB,ed. Butter worths, London. 1987:215-237.

Hirsch BE. “Myringoplasty and Tympanoplasty.” In Operative Otolaryngology/ Head&Neck Surgery. Eugene N Myers. Pages 1246-1261.

Vrabee JT, Deskin PW, Grady JJ. Metaanalysis of pediatric tympanoplasty. Arch Otolaryngol Head Neck Surg 1999; 125:530-4.

Caylan R, Titiz A, Falcioni M, de Donato GD, Russo A, Taibah AA, et al. Myringoplasty in children: factors influencing surgical outcome. Otolaryngol Head Neck Surg. 1998;118(5):709-13.

Sinyth GDL. พToynbee Menorial Lecture 1992:Facts and fantasies in modern otology:the ear doctor’s dilemma.” Journal of Laryngology and Otology. Vol 106, pp 591-596.

Podoshin L et al. WType 1 Tympanoplasty in Children.” American Journal of Otology. 17:293-296.

Derlacki EL. Office closure of central tympanic membrane perforations: a quarter century of experience. Trans Am Acad Ophthalmol Otolaryngol. Mar-Apr 1973;77(2);ORL53-66. [Medline].

DerLACKI el. Residual perforations after tympanoplasty;office technique for closure. Otolaryngol Clin North Am. Nov 1982; 15(4):861-7. [Medline].

P. Sheahan; T. O’Dwyer; A. Blayney. Results of type 1 tympanoplasty in children and parental perceptions of outcome of surgery. J Laryngol Otol. June 2002; Vol: 116, Page: 430-4.

Sheehy JL and Shelton C. “Tympanoplasty : To stage or not to stage.” Oto -HNS. Vol 104. No 3, pages 399-407.

Podoshin L et al. “Tympanoplasty in Adults: A Five-Year Survey.” ENT Journal. Vol 75, No 3. Pages 149- 156.

Halik JJ and Smyth GDL. “Longterm results of Tympanic Membrane Repair.” Oto-HNS. Vol 98, No 2. Pages 162-9.

Albu S et a I. “Prognostic Factors in Tympanoplasty.” American Journal of Otology. Vol 19:136-140.